These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15197699)

  • 1. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
    Furtado S; Payami H; Lockhart PJ; Hanson M; Nutt JG; Singleton AA; Singleton A; Bower J; Utti RJ; Bird TD; de la Fuente-Fernandez R; Tsuboi Y; Klimek ML; Suchowersky O; Hardy J; Calne DB; Wszolek ZK; Farrer M; Gwinn-Hardy K; Stoessl AJ
    Mov Disord; 2004 Jun; 19(6):622-9. PubMed ID: 15197699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The parkinsonian phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Kuo PC; Chang HC; Weng YH
    Arch Neurol; 2004 Jan; 61(1):35-8. PubMed ID: 14732617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report.
    Wilkins A; Brown JM; Barker RA
    Mov Disord; 2004 May; 19(5):593-5. PubMed ID: 15133829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCA2 may present as levodopa-responsive parkinsonism.
    Payami H; Nutt J; Gancher S; Bird T; McNeal MG; Seltzer WK; Hussey J; Lockhart P; Gwinn-Hardy K; Singleton AA; Singleton AB; Hardy J; Farrer M
    Mov Disord; 2003 Apr; 18(4):425-9. PubMed ID: 12671950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Yen TC; Tsai CH; Chen RS; Chang HC
    Mov Disord; 2002 Sep; 17(5):1046-51. PubMed ID: 12360557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.
    Kim JM; Hong S; Kim GP; Choi YJ; Kim YK; Park SS; Kim SE; Jeon BS
    Arch Neurol; 2007 Oct; 64(10):1510-8. PubMed ID: 17923635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?
    Charles P; Camuzat A; Benammar N; Sellal F; Destée A; Bonnet AM; Lesage S; Le Ber I; Stevanin G; Dürr A; Brice A;
    Neurology; 2007 Nov; 69(21):1970-5. PubMed ID: 17568014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6).
    Khan NL; Giunti P; Sweeney MG; Scherfler C; Brien MO; Piccini P; Wood NW; Lees AJ
    Mov Disord; 2005 Sep; 20(9):1115-9. PubMed ID: 15954136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.
    Infante J; Berciano J; Volpini V; Corral J; Polo JM; Pascual J; Combarros O
    Mov Disord; 2004 Jul; 19(7):848-852. PubMed ID: 15254952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular analysis of the CAG repeat among patients with Type-2 spinocerebellar ataxia in the Mexican population].
    Magaña JJ; Vergara MD; Sierra-Martínez M; García-Jiménez E; Rodríguez-Antonio F; Gómez Mdel R; Valdés-Flores M; Cisneros B
    Gac Med Mex; 2008; 144(5):413-8. PubMed ID: 19043961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
    Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis.
    Mutesa L; Pierquin G; Segers K; Vanbellinghen JF; Gahimbare L; Bours V
    J Trop Pediatr; 2008 Oct; 54(5):350-2. PubMed ID: 18499737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can ataxin-2 be down-regulated by allele-specific de novo DNA methylation in SCA2 patients?
    Bauer PO; Zumrova A; Matoska V; Mitsui K; Goetz P
    Med Hypotheses; 2004; 63(6):1018-23. PubMed ID: 15504570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
    Pulst SM; Santos N; Wang D; Yang H; Huynh D; Velazquez L; Figueroa KP
    Brain; 2005 Oct; 128(Pt 10):2297-303. PubMed ID: 16000334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2.
    Wang C; Xu Y; Feng X; Ma J; Xie S; Zhang Y; Tang BS; Chan P
    Neurobiol Aging; 2015 Jan; 36(1):545.e1-7. PubMed ID: 25189117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.
    Lee WY; Jin DK; Oh MR; Lee JE; Song SM; Lee EA; Kim GM; Chung JS; Lee KH
    Arch Neurol; 2003 Jun; 60(6):858-63. PubMed ID: 12810491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism.
    Tan EK; Tong J; Pavanni R; Wong MC; Zhao Y
    Mov Disord; 2007 Oct; 22(13):1971-4. PubMed ID: 17712857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between cerebral vascular disease and parkinsonism: The VADO study.
    Antonini A; Vitale C; Barone P; Cilia R; Righini A; Bonuccelli U; Abbruzzese G; Ramat S; Petrone A; Quatrale R; Marconi R; Ceravolo R; Stefani A; Lopiano L; Zappia M; Capus L; Morgante L; Tamma F; Tinazzi M; Colosimo C; Guerra UP
    Parkinsonism Relat Disord; 2012 Jul; 18(6):775-80. PubMed ID: 22531611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex phenotypes in an Indian family with homozygous SCA2 mutations.
    Ragothaman M; Sarangmath N; Chaudhary S; Khare V; Mittal U; Sharma S; Komatireddy S; Chakrabarti S; Mukerji M; Juyal RC; Thelma BK; Muthane UB
    Ann Neurol; 2004 Jan; 55(1):130-3. PubMed ID: 14705123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
    Boesch SM; Donnemiller E; Müller J; Seppi K; Weirich-Schwaiger H; Poewe W; Wenning GK
    Mov Disord; 2004 Nov; 19(11):1320-5. PubMed ID: 15390003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.